Behbehani, Gregory K <br/><br/>
Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy.  [electronic resource] 

 -  Cancer discovery  Sep 2015 
 - 988-1003 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>2159-8290 
<br/><br/><label>Standard No.: </label>10.1158/2159-8290.CD-15-0298  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers<br/>Bone Marrow Cells--metabolism<br/>Bone Marrow Examination<br/>Cell Cycle--genetics<br/>Cluster Analysis<br/>Flow Cytometry<br/>Genotype<br/>Humans<br/>Immunophenotyping<br/>Karyotype<br/>Leukemia, Myeloid, Acute--diagnosis<br/>Neoplastic Stem Cells--metabolism<br/>Phenotype<br/>Reproducibility of Results<br/>Treatment Outcome